AUTOIMMUNE BULLOUS DISEASE

Clinical trials for AUTOIMMUNE BULLOUS DISEASE explained in plain language.

Never miss a new study

Get alerted when new AUTOIMMUNE BULLOUS DISEASE trials appear

Sign up with your email to follow new studies for AUTOIMMUNE BULLOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New antibody therapy aims to stop blistering skin disease

Disease control Recruiting now

This study tests a new drug called CM336 in 30 adults with moderate to severe autoimmune bullous disease, a condition where the immune system attacks the skin causing painful blisters. The drug targets specific immune cells to reduce this attack. The main goal is to see if the dr…

Matched conditions: AUTOIMMUNE BULLOUS DISEASE

Phase: PHASE2 • Sponsor: Shandong First Medical University • Aim: Disease control

Last updated May 15, 2026 11:54 UTC

AUTOIMMUNE BULLOUS DISEASE

Get alerted when new AUTOIMMUNE BULLOUS DISEASE trials appear

New antibody therapy aims to stop blistering skin disease